The effector functions of NKG2C have largely been demonstrated in the context of viral infections, however, they may also operate in cancer as NKG2C+ NK cells have recently demonstrated potent cytotoxicity against HLA-C:KIR mismatched leukemic cells [16]. The gene discussed is HLA-C; the disease is cancer.